Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

Similar articles for PubMed (Select 24395436)

1.

Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: influence on cure rates and risk of second cancer.

Levinsen M, Rotevatn EØ, Rosthøj S, Nersting J, Abrahamsson J, Appell ML, Bergan S, Bechensteen AG, Harila-Saari A, Heyman M, Jonsson OG, Maxild JB, Niemi M, Söderhäll S, Schmiegelow K; Nordic Society of Paediatric Haematology, Oncology.

Pediatr Blood Cancer. 2014 May;61(5):797-802. doi: 10.1002/pbc.24921. Epub 2014 Jan 3.

PMID:
24395436
2.

Nyttan av farmakogenetik för en mer individualiserad behandling - Exemplet tiopuriner vid inflammatorisk tarmsjukdom och barnleukemi.

Lindqvist Appell M, Mårtensson LG, Almer S, Peterson C.

Lakartidningen. 2015 Jun 30;112. pii: DF7L. Swedish.

PMID:
26126006
3.

Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia.

Tanaka Y, Kato M, Hasegawa D, Urayama KY, Nakadate H, Kondoh K, Nakamura K, Koh K, Komiyama T, Manabe A.

Br J Haematol. 2015 Jun 2. doi: 10.1111/bjh.13518. [Epub ahead of print]

PMID:
26033531
4.

Molecular insight into thiopurine resistance: transcriptomic signature in lymphoblastoid cell lines.

Chouchana L, Fernández-Ramos AA, Dumont F, Marchetti C, Ceballos-Picot I, Beaune P, Gurwitz D, Loriot MA.

Genome Med. 2015 Apr 18;7(1):37. doi: 10.1186/s13073-015-0150-6. eCollection 2015.

5.

Inherited genetic variation in childhood acute lymphoblastic leukemia.

Moriyama T, Relling MV, Yang JJ.

Blood. 2015 Jun 25;125(26):3988-95. doi: 10.1182/blood-2014-12-580001. Epub 2015 May 21. Review.

PMID:
25999454
6.

Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003.

Lennard L, Cartwright CS, Wade R, Vora A.

Br J Haematol. 2015 May 5. doi: 10.1111/bjh.13469. [Epub ahead of print]

PMID:
25940902
7.

Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.

Yang JJ, Landier W, Yang W, Liu C, Hageman L, Cheng C, Pei D, Chen Y, Crews KR, Kornegay N, Wong FL, Evans WE, Pui CH, Bhatia S, Relling MV.

J Clin Oncol. 2015 Apr 10;33(11):1235-42. doi: 10.1200/JCO.2014.59.4671. Epub 2015 Jan 26.

PMID:
25624441
8.

Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics.

Lennard L, Cartwright CS, Wade R, Vora A.

Br J Haematol. 2015 Apr;169(2):228-40. doi: 10.1111/bjh.13240. Epub 2014 Nov 29.

PMID:
25441457
9.

Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity.

Levinsen M, Rosthøj S, Nygaard U, Heldrup J, Harila-Saari A, Jonsson OG, Bechensteen AG, Abrahamsson J, Lausen B, Frandsen TL, Weinshilboum RM, Schmiegelow K.

Cancer Chemother Pharmacol. 2015 Jan;75(1):59-66. doi: 10.1007/s00280-014-2613-7. Epub 2014 Oct 28.

PMID:
25347948
10.

Association of ITPA genotype with event-free survival and relapse rates in children with acute lymphoblastic leukemia undergoing maintenance therapy.

Smid A, Karas-Kuzelicki N, Milek M, Jazbec J, Mlinaric-Rascan I.

PLoS One. 2014 Oct 10;9(10):e109551. doi: 10.1371/journal.pone.0109551. eCollection 2014.

11.

Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology.

Ranta S, Tuckuviene R, Mäkipernaa A, Albertsen BK, Frisk T, Tedgård U, Jónsson ÓG, Pruunsild K, Gretenkort Andersson N, Winther Gunnes M, Saulyte Trakymiene S, Frandsen T, Heyman M, Ruud E, Helgestad J.

Br J Haematol. 2015 Feb;168(4):547-52. doi: 10.1111/bjh.13162. Epub 2014 Oct 7.

PMID:
25288392
12.

Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.

Applebaum MA, Henderson TO, Lee SM, Pinto N, Volchenboum SL, Cohn SL.

Pediatr Blood Cancer. 2015 Jan;62(1):128-33. doi: 10.1002/pbc.25249. Epub 2014 Sep 23.

PMID:
25251613
13.

Medication errors on oral chemotherapy in children with acute lymphoblastic leukemia in a developing country.

Oberoi S, Trehan A, Marwaha RK.

Pediatr Blood Cancer. 2014 Dec;61(12):2218-22. doi: 10.1002/pbc.25203. Epub 2014 Aug 30.

PMID:
25175850
14.

Pharmacokinetics of 6-Thioguanine and 6-Mercaptopurine Combination Maintenance Therapy of Childhood ALL: Hypothesis and Case Report.

Nielsen SN, Frandsen TL, Nersting J, Hjalgrim LL, Schmiegelow K.

J Pediatr Hematol Oncol. 2014 Aug 28. [Epub ahead of print]

PMID:
25171455
15.

Pharmacogenetics of childhood acute lymphoblastic leukemia.

Lopez-Lopez E, Gutierrez-Camino A, Bilbao-Aldaiturriaga N, Pombar-Gomez M, Martin-Guerrero I, Garcia-Orad A.

Pharmacogenomics. 2014 Jul;15(10):1383-98. doi: 10.2217/pgs.14.106. Review.

PMID:
25155938
16.

Impact of SLCO1B1 521T > C variant on leucovorin rescue and risk of relapse in childhood acute lymphoblastic leukemia treated with high-dose methotrexate.

Zhang HN, He XL, Wang C, Wang Y, Chen YJ, Li JX, Niu CH, Gao P.

Pediatr Blood Cancer. 2014 Dec;61(12):2203-7. doi: 10.1002/pbc.25191. Epub 2014 Aug 17.

PMID:
25130190
17.

Pharmacogenetic studies in children with acute lymphoblastic leukemia in Argentina.

Aráoz HV, D'Aloi K, Foncuberta ME, Sanchez La Rosa CG, Alonso CN, Chertkoff L, Felice M.

Leuk Lymphoma. 2015 May;56(5):1370-8. doi: 10.3109/10428194.2014.951844. Epub 2014 Nov 20.

PMID:
25110820
18.

Cure rates of childhood acute lymphoblastic leukemia in Lithuania and the benefit of joining international treatment protocol.

Vaitkevičienė G, Matuzevičienė R, Stoškus M, Žvirblis T, Ragelienė L, Schmiegelow K.

Medicina (Kaunas). 2014;50(1):28-36. doi: 10.1016/j.medici.2014.05.005. Epub 2014 Jun 6.

19.

Treatment-related myelodysplastic syndrome in a child with acute myeloid leukemia and TPMT heterozygosity.

Stensman LM, Kjeldsen E, Nersting J, Schmiegelow K, Hasle H.

J Pediatr Hematol Oncol. 2015 May;37(4):e242-4. doi: 10.1097/MPH.0000000000000211.

PMID:
25000470
20.

Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients.

Wesołowska-Andersen A, Borst L, Dalgaard MD, Yadav R, Rasmussen KK, Wehner PS, Rasmussen M, Ørntoft TF, Nordentoft I, Koehler R, Bartram CR, Schrappe M, Sicheritz-Ponten T, Gautier L, Marquart H, Madsen HO, Brunak S, Stanulla M, Gupta R, Schmiegelow K.

Leukemia. 2015 Feb;29(2):297-303. doi: 10.1038/leu.2014.205. Epub 2014 Jul 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk